Tag Archives: Blood cancer drug shows signs of helping COVID-19 patients

FRANKFURT: AstraZeneca’s cancer drug Calquence has shown initial signs of helping hospitalised COVID-19 patients get through the worst of the disease, as researchers scramble to repurpose existing treatments to help fight the deadly infection. Results from the preliminary research involving 19 patients, which was backed by the United States National Institutes of Health, encouraged the British drugmaker to explore the …

Read More »